Investor Relations
Sep 14, 2018
OPKO Confirms Resumption of Common Stock Trading on Nasdaq MORE >>
Sep 11, 2018
OPKO Comments on Continued Nasdaq Halt of Trading of Common Stock MORE >>
Sep 07, 2018
OPKO Comments on SEC Complaint MORE >>
Sep 04, 2018
OPKO Initiates RAYALDEE Phase 2 Trial in Dialysis Patients MORE >>

SEC Filing Details

Document Details

Form
Filing Date
May 30, 2018
Document Date
May 29, 2018
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
OPKO Health, Inc.
Filer
Fishel Robert Scott